Showing of 0 - 10 from 12 results
Biotechnology - Total results - 12
Sep 16, 2016
Dr Reddy's inks pact with US-based Amgen to market three drugs in IndiaUnder the terms of collaboration, DRL will commercialise Xgeva (denosumab), Vectibix (panitumumab) and Prolia (denosumab) in India
May 23, 2016
India tightens rules over sale of Monsanto's GM cotton seedsIndia has tightened rules for the sale of genetically-modified cotton seeds, a government order said, in a move that will cap royalties for any new variety that the market's sole supplier - U.S.-based Monsanto Co - decides to develop and sell.
Sep 08, 2015
Too little, too late? 3 years after Monsanto’s Bt gene went off patent, govt wakes upThe government has suggested to the Indian Council of Agricultural Research (ICAR) that the gene be incorporated in re-sowable straight line varieties and supplied cheaper to farmers than Bt cotton hybrids
Jun 21, 2014
U.S. CDC says more lab workers may have been exposed to anthraxCHICAGO (Reuters) - U.S. authorities increased to 84 people their count of government workers potentially exposed to live anthrax at three laboratories in Atlanta as they investigated a breach in safety procedures for handling the deadly pathogen
Feb 19, 2014
Biotech queen Kiran Mazumdar-Shaw heads IIM-BangaloreIndia's biotechnology queen Kiran Mazumdar-Shaw is the new chairperson of the prestigious Indian Institute of Management-Bangalore (IIM-B)
Jan 13, 2013
Why we must clear the GMO clutter while we still canPushed by the government and riding on hired science, the GM industry is slowly but surely descending on us. But we must demand answers to a few reasonable questions.
Apr 30, 2012
Brain networks explain why some teenagers smokeIn the largest imaging study of its kind, involving the brains of 1,896 14-year-olds, scientists have discovered a number of previously "unknown networks" that go a long way towards answering why some teenagers smoke and some don't.
Mar 13, 2012
Pfizer scraps insulin deal with Biocon, stock tumblesUS drugmaker Pfizer said on Monday it has scrapped a deal to sell insulin products made by Biocon Ltd, in what is set to be a major blow for India's largest listed biotech firm.
Jan 25, 2012
Biocon net profit falls 15 percent; shares downShares in Biocon Ltd., India's top-listed biotechnology company, fell as much as 4.4 percent on Wednesday, after its December quarter net profit fell 15 percent on lower licensing income, which the company expects to rise in future.
Sep 13, 2011
Biocon to list services unit in 18 monthsMazumdar-Shaw also said Biocon is focusing on posting $1 billion in revenue in three to five years, helped by growth in its insulin business.